EcoDrugPlus

Coagulation Factor Iiia

Ensembl ID : ENSAPEG00000010834
Gene Symbol: F3A
1 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSAPEG00000009519
Gene Symbol: F7L
1 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSAPEG00000009274
Gene Symbol: F10
1 Cross references
241 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSAPEG00000006789
Gene Symbol: F10
1 Cross references
240 Possible Orthologues:

Coiled-Coil Domain Containing 6a

Ensembl ID : ENSAPEG00000006084
Gene Symbol: CCDC6A
1 Cross references
208 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSAPEG00000016423
Gene Symbol: CSF1RA
1 Cross references
207 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAPEG00000003526
Gene Symbol: CRHR1
1 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSAPEG00000002429
Gene Symbol: CCND1
1 Cross references
231 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSAPEG00000001888
Gene Symbol: CDK1
1 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSAPEG00000009199
Gene Symbol: CDK2
1 Cross references
203 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSAPEG00000009818
Gene Symbol: CDK4
1 Cross references
239 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSAPEG00000002446
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).